The global atherosclerosis treatments market is poised for steady growth, with an estimated valuation of USD 59,514.3 million by 2033, increasing from its current value of USD 45,165.6 million in 2023. This represents a compound annual growth rate (CAGR) of 2.8% over the forecast period from 2023 to 2033.
A significant driver of this growth is the rising prevalence of cardiovascular disorders worldwide, which is increasing the demand for effective treatments and therapies for atherosclerosis, a leading cause of heart disease. As the global burden of cardiovascular conditions continues to escalate, the atherosclerosis market is expected to witness sustained expansion over the next decade.
This growth highlights the critical need for advancements in treatment options and innovations within the healthcare sector aimed at addressing this widespread condition.
Crucial information and forecast statistics covered in the Atherosclerosis market report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic.
COVID-19 Impact Analysis on Atherosclerosis Market
The recent outbreak of the COVID-19 has turned the spotlight on the healthcare industry, and subsequently impacted the Atherosclerosis market. Severe shortages of critical medical supplies and a rapid rise in number of COVID-19 cases have resulted into a revolution rather than evolution in the healthcare ecosystems. Consequently, the impact is noticeable in the Atherosclerosis market.
Following government’s measures, particularly social distancing norms and stay-at-home orders, doctors are delaying or postponing elective surgeries unless critical to prevent the spread of the virus to individuals with comorbidities or chronic conditions. Additionally, movement restrictions and supply chain disruptions have created a logistical nightmare for market players, leading to severe product shortages in the global marketplace.
The FMI’s report includes an interesting chapter on preliminary impact of the COVID-19 on the Atherosclerosis market. This allows both leading and emerging market players to understand the market scenario during a crisis and aids them in making sound decisions to gain a distinct competitive edge.
A Old Full Report Analysis Click Here
Atherosclerosis Market: Segmentation
Valuable information covered in the FMI’s Atherosclerosis market report has been segregated into key segments and sub-segments.
By Therapy
- Medications
- Cholesterol-lowering medications
- Antiplatelet drugs and anticoagulants
- Beta blockers
- Diuretics, or water pills
- Angiotensin converting enzyme (ace) inhibitors
- Others
By Surgery
- Bypass surgery (Coronary Artery Bypass Grafting (CABG))
- Angioplasty
- Atherectomy
Key players covered in the report include:
- GlaxoSmithKline plc.
- Merck & Co., Inc.
- F. Hoffmann-La Roche Ltd.
- Isis Pharmaceuticals, Inc.
- Anthera Pharmaceuticals
- Novartis AG
- Sanofi
- Johnson and Johnson
- Bayer AG
- The Medicine Company
- Cardium Therapeutics
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
